Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Wingderm® Has Unveiled the Latest Research of Mesoskin for Mesotherapy Treatment at AMWC 2023-10-24 09:23
Alphamab Oncology updated data from two studies of KN026 in combination with docetaxel for HER2-positive breast cancer at ESMO 2023-10-24 08:41
Alphamab Oncology Announces New Data from Multiple Studies of KN046 with Lung Cancer and Thymic Carcinoma at ESMO 2023-10-24 08:41
LifeSpan Vision Ventures Invests in Matter Bio 2023-10-24 03:40
A Safer Tomorrow: AESOP Technology's Battle Against Look-Alike, Sound-Alike Medication Errors 2023-10-24 00:03
LBB Specialties Announces Principal Partnership with Viscofan 2023-10-23 23:00
XINGIMAGING and MITRO BIOTECH CO., LTD. MERGE TO DELIVER FULL-SERVICE CRO OPERATIONS TO GLOBAL RESEARCH INITIATIVES 2023-10-23 22:38
Genesis MedTech initiates enrollment in its North American Early Feasibility Study using the J-Valve™ Transfemoral System for patients with severe aortic regurgitation 2023-10-23 22:00
Transcenta Unveils Updated Efficacy Data from Osemitamab (TST001) Plus CAPOX as First-Line Treatment for G/GEJ Cancer Study at ESMO 2023 2023-10-23 21:48
Certa Therapeutics' FT011 Granted US FDA Orphan Drug Designation for the Treatment of Systemic Sclerosis 2023-10-23 21:30
WAT Medical Donates to the Canadian Red Cross and Peach Arch Hospital 2023-10-23 21:00
AI Diagnostic Platform Company Noul, unveils the result of Malaria study in Ethiopia and Ghana 2023-10-23 21:00
COSMAX NBT Showcases Exclusive Materials and Formulations at SSW 2023, Strengthening its Presence in the U.S. Market 2023-10-23 21:00
VUNO Secures FDA 510(k) Clearance for VUNO Med®-DeepBrain® 2023-10-23 21:00
Zhongchao Inc. Launches Breast Cancer Follow-up Visit and Health Management Patient Guide Program on Breast Cancer Awareness Day 2023-10-23 20:00
Skyhawk Therapeutics Receives HREC Approval for a Phase 1 Study of its SKY-0515 RNA-Targeting Small Molecule for Huntington's Disease 2023-10-23 20:00
Live from ESMO 2023 | Oral Report Featuring Latest Data of Pelcitoclax (APG-1252) Combined with Osimertinib Demonstrates Potential as a New Treatment Option for TP53-and EGFR-Mutant NSCLC 2023-10-23 19:56
Mabwell Announces Latest Clinical Progress and Data to be Reported on ESMO 2023 of 2 Novel Drugs 2023-10-23 18:25
The team from Kelun-Biotech held a meeting with representatives from MSD in Madrid, Spain 2023-10-23 18:16
JINGHAO MEDICAL's self-fitting OTC hearing aids received FDA 510(k) approval 2023-10-23 18:01
1 84 85 86 87 88 1502